India’s homegrown COVID jab, Covaxin is ‘highly efficacious’: Study
November 12, 2021
Covaxin, the first COVID-19 vaccine developed in India, is “highly efficacious” and presents no safety concerns, as per a study published in the medical journal Lancet. Covaxin gained emergency approval from the World Health Organization last week, the eighth jab
